All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
| Tue 1982-02-16? to Fri 2026-01-30 |
YTD
Return |
TRR
Price |
||||
|---|---|---|---|---|---|---|
| TEVA × |
+8.99%
2026-01-30 |
27.09 TRR
2026-01-30 |
||||
| Teva Pharma Industries Ltd ADR NYSE Common Stock | ||||||
| Tue 1982-02-16? to Fri 2026-01-30 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| TEVA × |
+2,609.06%
+7.79%/yr |
+10.84%/yr
(R2=0.576) |
||||
| Teva Pharma Industries Ltd ADR NYSE Common Stock | ||||||
| Tue 1982-02-16? to Fri 2026-01-30 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| TEVA × |
$10,000.00
1982-02-16 |
$270,906.20
2026-01-30 |
||||
| Teva Pharma Industries Ltd ADR NYSE Common Stock | ||||||
| Year | TEVA |
|---|---|
| 2026 (YTD) | +8.99% |
| 2025 | +37.87% |
| 2024 | +105.25% |
| 2023 | +10.75% |
| 2022 | +6.95% |
| 2021 | −22.45% |
| 2020 | −2.83% |
| 2019 | −37.88% |
| 2018 | −20.15% |
| 2017 | −47.07% |
| 2016 | −44.35% |
| 2015 | +15.86% |
| 2014 | +46.25% |
| 2013 | +9.26% |
| 2012 | −6.74% |
| 2011 | −23.31% |
| 2010 | −7.29% |
| 2009 | +30.07% |
| 2008 | −7.45% |
| 2007 | +45.05% |
| 2006 | −28.92% |
| 2005 | +40.43% |
| 2004 | +2.72% |
| 2003 | +45.14% |
| 2002 | +23.08% |
| 2001 | −16.81% |
| 2000 | +100.00% |
| 1999 | +72.45% |
| 1998 | −14.83% |
| 1997 | −6.99% |
| 1996 | +5.95% |
| 1995 | +89.39% |
| 1994 | −20.74% |
| 1993 | +34.70% |
| 1992 | +127.28% |
| 1991 | +60.89% |
| 1990 | −6.55% |
| 1989 | +65.69% |
| 1988 | +6.06% |
| 1987 | −3.94% |
| 1986 | +129.72% |
| 1985 | +198.93% |
| 1984 | −34.87% |
| 1983 | −74.41% |
| 1982 | −46.63% |
| Tue 1982-02-16? to Fri 2026-01-30 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| TEVA × | −62.61% |
−93.82%
1984-11-19 |
||||
| Teva Pharma Industries Ltd ADR NYSE Common Stock | ||||||